Skip to main content
SpringerLink
Log in

Severe Immune Dysfunction after Lethal Neutron Irradiation in a JCO Nuclear Facility Accident Victim

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The optimal treatment for the hematological toxicity of acute radiation syndrome (ARS) is not fully established, especially in cases of high-dose nonuniform irradiation by mixed neutrons and γ-rays, because estimation of the irradiation dose (dosimetry) and prediction of autologous hematological recovery are complicated. For the treatment of ARS, we performed HLA-DRB1—mismatched unrelated umbilical cord blood transplantation (CBT) for a nuclear accident victim who received 8 to 10 GyEq mixed neutron and γ-ray irradiation at the JCO Co. Ltd. nuclear processing facility in Tokaimura, Japan. Donor/ recipient mixed chimerism was attained; thereafter rapid autologous hematopoietic recovery was achieved in concordance with the termination of immunosuppressants. Immune function examined in vitro showed recovery of the autologous immune system was severely impaired. Although the naive T-cell fraction and the helper T-cell subtype 1 fraction were increased, the mitogenic responses of T-cells and the allogeneic mixed leukocyte reaction were severely suppressed. Endogenous immunoglobulin production was also suppressed until 120 days after the accident. Although skin transplantation for ARS was successful, the patient died of infectious complications and subsequent acute respiratory distress syndrome 210 days after the accident. These results suggest that fast neutrons in doses higher than 8 to 10 Gy cause complete abrogation of the human immune system, which may lead to fatal outcome even if autologous hematopoiesis recovers. The roles of transplantation, autologous hematopoietic recovery, chimerism, immune suppression, and immune function are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baranov A, Gale RP, Guskova A, et al. Bone marrow transplantation after the Chernobyl nuclear accident.N Engl J Med. 1989;321:205–212.

    Article  CAS  PubMed  Google Scholar 

  2. Diagnosis and Treatment of Radiation Injuries. Safety reports series no. 2. Vienna: International Atomic Energy Agency, 1998.

  3. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from a HLA identical sibling.N Engl J Med. 1989;321:1174–1178.

    Article  CAS  PubMed  Google Scholar 

  4. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated marrow reconstitution.Proc Natl Acad Sci U S A. 1995;92:10119–10122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.N Engl J Med. 1996;335:157–166.

    Article  CAS  PubMed  Google Scholar 

  6. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease.Blood. 1996;88:795–802.

    PubMed  CAS  Google Scholar 

  7. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation.Blood. 1997;90:4665–4678.

    PubMed  CAS  Google Scholar 

  8. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors.N Engl J Med. 1997;337:373–381.

    Article  CAS  PubMed  Google Scholar 

  9. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors.N Engl J Med. 1998;339:1565–1577.

    Article  CAS  PubMed  Google Scholar 

  10. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host diseases in children who have received a cord blood or bone marrow transplantation from an HLA-identical sibling.N Engl J Med. 2000;342:1846–1854.

    Article  CAS  PubMed  Google Scholar 

  11. Barker JN, Davies SM, DeFor T, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor marrow: results of a matched-pair analysis.Blood. 2001;97:2957–2961.

    Article  CAS  PubMed  Google Scholar 

  12. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.Blood. 2001;97:2962–2971.

    Article  CAS  PubMed  Google Scholar 

  13. Laporte JP, Gorin NC, Rubinstein P, et al. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia.N Engl J Med. 1996;335:167–170.

    Article  CAS  PubMed  Google Scholar 

  14. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.N Engl J Med. 2001;344:1815–1822.

    Article  CAS  PubMed  Google Scholar 

  15. Sanz GF, Saavedra S, Jimenez C, et al. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.Bone Marrow Transplant. 2001;27:693–701.

    Article  CAS  PubMed  Google Scholar 

  16. Nagayama H, Nakayama K, Yasuo K, et al. Immunological reconstitution after cord blood transplantation for an adult patient.Bone Marrow Transplant. 1999;24:211–213.

    Article  CAS  PubMed  Google Scholar 

  17. Machida U, Tojo A, Ooi J, et al. Refractory facial cellulitis following cosmetic rhinoplasty after cord-blood stem cell transplantation.Int J Hematol. 2000;72:98–100.

    PubMed  CAS  Google Scholar 

  18. Report on the Preliminary Fact Finding Mission following the Accident at the Nuclear Fuel Processing Facility in Tokaimura, Japan. Vienna: International Atomic Energy Agency, 1999.

  19. Kawachi K. Initial response of NIRS.Proceedings of International Symposium on the Criticality Accident in Tokaimura: Medical Aspects of Radiation Emergency. Chiba, Japan: National Institute of Radiological Science, 2001:24–34.

    Google Scholar 

  20. Akashi M. Dose estimation of victims severely exposed based on initial symptoms in the criticality accident in Tokaimura.Proceedings of International Symposium on the Criticality Accident in Tokaimura: Medical Aspects of Radiation Emergency. Chiba, Japan: National Institute of Radiological Science, 2001:72–80.

    Google Scholar 

  21. Nagayama H, Takahashi TA, Misawa K, et al. Case presentation of worker B.Proceedings of International Symposium on the Criticality Accident in Tokaimura: Medical Aspects of Radiation Emergency. Chiba, Japan: National Institute of Radiological Science, 2001:154–158.

    Google Scholar 

  22. Iseki T, Nagayama H, Ooi J, et al. Unrelated cord blood transplantation for a heavily irradiated patient.Proceedings of International Symposium on the Criticality Accident in Tokaimura: Medical Aspects of Radiation Emergency. Chiba, Japan: National Institute of Radiological Science, 2001:220–227.

    Google Scholar 

  23. Nagayama H, Misawa K, Tanaka H, et al. Transient hematopoietic stem cell rescue using umbilical cord blood for a lethally irradiated nuclear accident victim.Bone Marrow Transplant. 2002;29:197–204.

    Article  CAS  PubMed  Google Scholar 

  24. Koike S, Ando K. Relative biological effectiveness of fast neutrons in murine tissues.Proceedings of International Symposium on the Criticality Accident in Tokaimura: Medical Aspects of Radiation Emergency. Chiba, Japan: National Institute of Radiological Science, 2001:66–71.

    Google Scholar 

  25. Sato K, Nagayama H, Takahashi TA. Aberrant CD3- and CD28-mediated signaling events in cord blood T cells are associated with dysfunctional regulation of Fas ligand-mediated cytotoxicity.J Immunol. 1999;162:4464–4471.

    PubMed  CAS  Google Scholar 

  26. Hill RS, Peterson FB, Storb R, et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.Blood. 1986;67:811–816.

    PubMed  CAS  Google Scholar 

  27. Chiba S, Saito A, Ogawa S, et al. Allogeneic peripheral blood stem cell transplantation for a victim of the criticality accident in Tokaimura.Proceedings of International Symposium on the Criticality Accident in Tokaimura: Medical Aspects of Radiation Emergency. Chiba, Japan: National Institute of Radiological Science, 2001:212–218.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Medical Science, University of Tokyo, Tokyo, Japan

    Hitomi Nagayama, Jun Ooi, Akira Tomonari, Tohru Iseki, Arinobu Tojo, Kenzaburo Tani, Tsuneo A. Takahashi, Naohide Yamashita & Shigetaka Asano

  2. Division of Hematology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan

    Hitomi Nagayama

Authors
  1. Hitomi Nagayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Ooi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akira Tomonari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tohru Iseki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arinobu Tojo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenzaburo Tani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tsuneo A. Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Naohide Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shigetaka Asano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hitomi Nagayama.

About this article

Cite this article

Nagayama, H., Ooi, J., Tomonari, A. et al. Severe Immune Dysfunction after Lethal Neutron Irradiation in a JCO Nuclear Facility Accident Victim. Int J Hematol 76, 157–164 (2002). https://doi.org/10.1007/BF02982579

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02982579

Key words

Search

Navigation